These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33515576)

  • 1. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
    Mohad V; Lungova V; Verheyden J; Thibeault SL
    Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nantie LB; Young RE; Paltzer WG; Zhang Y; Johnson RL; Verheyden JM; Sun X
    Development; 2018 Nov; 145(21):. PubMed ID: 30305289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells.
    Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A
    FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
    FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
    Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
    J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.
    Szymaniak AD; Mi R; McCarthy SE; Gower AC; Reynolds TL; Mingueneau M; Kukuruzinska M; Varelas X
    Elife; 2017 May; 6():. PubMed ID: 28492365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway.
    Vanyai HK; Prin F; Guillermin O; Marzook B; Boeing S; Howson A; Saunders RE; Snoeks T; Howell M; Mohun TJ; Thompson B
    Development; 2020 Nov; 147(21):. PubMed ID: 32994166
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
    Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
    Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation.
    Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P
    Elife; 2024 Jul; 13():. PubMed ID: 39051998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
    Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
    Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation.
    McNeill H; Reginensi A
    J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lats2 modulates adipocyte proliferation and differentiation via hippo signaling.
    An Y; Kang Q; Zhao Y; Hu X; Li N
    PLoS One; 2013; 8(8):e72042. PubMed ID: 23977200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
    He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
    EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LATS2 condensates organize signalosomes for Hippo pathway signal transduction.
    Qin M; Geng E; Wang J; Yu M; Dong T; Li S; Zhang X; Lin J; Shi M; Li J; Zhang H; Chen L; Cao X; Huang L; Wang M; Li Y; Yang XP; Zhao B; Sun S
    Nat Chem Biol; 2024 Jun; 20(6):710-720. PubMed ID: 38200110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.
    Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X
    Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.